FDA-approved drugs in each class GLP-1 receptor agonist medications include semaglutide (Ozempic, Wegovy, Rybelsus), tirzepatide (Mounjaro, Zepbound also a GIP agonist), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and exenatide (Byetta, Bydureon)
Yes, semaglutide is FDA-approved for treating type 2 diabetes and chronic weight management
Microcurrent devices, on the other hand, target facial muscles with electrical impulses to lift and tone your face
At TrimRx, we believe that clear information is the first step toward a successful health journey
Stephen and Drew Sinatra present another installment of their Pulse Check series, where they talk about trending health topics, emerging research, and what you should know right now